The Saudi Seventh Investment Company agreed to acquire additional 6.5% stake in Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. (CASE:RMDA) for GGP 135 million on April 26, 2022. Under the terms The Saudi Seventh Investment Company will acquirem65 million shares for EGP 2.08 per share. The Saudi Seventh Investment Company will increase stake from 4.51% to 11.01% in Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E.